Alan Roemer

Alan Roemer

Chairman at
UTILITY therapeutics Ltd.

Net worth: 92 591 $ as of 2026-05-30

56 year
Health Technology
Consumer Services
Finance

Profile

Alan S.
Roemer
is Chairman at UTILITY therapeutics Ltd. since 2020.
Mr. Roemer is Director at DC Brau Brewing LLC.
Mr. Roemer is Trustee at Helene Fuld College of Nursing since 2014.
Former roles include Chairman at IN8bio, Inc. from 2020 to 2026, Director at Bit Bio Ltd. from 2021 to 2024, Managing Director at Trout Capital LLC from 2009 to 2014, Director at Sompharmaceuticals SA from 2012 to 2016, Managing Director at The Trout Group LLC from 2009 to 2014, Director at Envisagenics, Inc. from 2021 to 2023, Independent Director at NexImmune, Inc. from 2019 to 2024, Principal at Bank of America Corp., Chief Financial Officer & Treasurer at Azelon Pharmaceuticals, Inc. from 2008 to 2009, Vice President-Investor Relations at Pharmasset, Inc. from 1999 to 2008, Consultant at Deloitte Consulting LLP, Consultant at Booz Allen Hamilton International (U.K.) Ltd., Chief Financial & Accounting Officer at Sio Gene Therapies, Inc. in 2015, Chief Financial Officer at Axovant Sciences, Inc. in 2015, and Senior Vice President & Member at Roivant Sciences, Inc. from 2014 to 2019.
Education includes undergraduate studies at Georgetown University, an MBA from Goizueta Business School-Emory, and graduate studies at Rollins School of Public Health.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-21 49,514 ( 0.5% ) 92 591 $ 2026-05-30

Alan Roemer active positions

CompaniesPositionStart
Director/Board Member -
Chairman 2020-02-29
Director/Board Member 2014-05-31

Former positions of Alan Roemer

CompaniesPositionEnd
IN8BIO, INC. Chairman 2026-02-27
Director/Board Member 2024-10-31
NEXIMMUNE, INC. Chairman 2019-12-15
Director/Board Member 2023-01-31
Corporate Officer/Principal 2019-07-31
See the detail of Alan Roemer's experience

Training of Alan Roemer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

53

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies21

Finance

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Commercial Services

Consumer Services

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Sompharmaceuticals SA

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!